ACAT1 (P24752) variants and mutations
ACAT1 (also known as P24752) is a human protein-coding gene encoding an acetyl-CoA acetyltransferase, mitochondrial protein. It catalyzes the reversible conversion of two acetyl-CoA molecules to acetoacetyl-CoA in mitochondrial ketone-body and isoleucine metabolism. Biallelic deficiency causes beta-ketothiolase deficiency, which predisposes to recurrent episodes of severe ketoacidosis. This analysis covers 715 ACAT1 variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes beta-ketothiolase deficiency, hereditary disease, and Abnormality of the skeletal system. Example ACAT1 variants include M1K, M1L, and M1T.
Variant analysis overview
- Gene: ACAT1
- Protein: P24752
- UniProt accession: P24752
- Organism: Homo sapiens
- Variants analyzed: 715
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 520 unspecified-consequence records; 107 missense variants; 47 synonymous variants; 24 frameshift variants; 1 protein altering variant; 2 in-frame deletions; 3 splice-region variants; 4 stop-gained variants; 7 substitution
- Prediction scores: 560 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: beta-ketothiolase deficiency, hereditary disease, Abnormality of the skeletal system, neoplasm, Uterine leiomyoma, nonpapillary renal cell carcinoma, colorectal carcinoma, myopia, lipoma, bladder transitional cell carcinoma, prostate cancer, prostate carcinoma.
Protein structure and variant hotspots
- Protein features: 9 binding sites; 24 post-translational modification sites.
- PTM context: 17 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ACAT1 variants
Examples include M1K, M1L, M1T, M1V, A2D, A2V, A2S, A2P. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1K (p.Met1Lys), rs120074142, ClinGen CA252463, ClinVar RCV000002972, MetaLR 0.63, MetaSVM 0.41, Pathogenic, Deficiency of acetyl-CoA acetyltransferase
- M1L (p.Met1Leu), rs1305448140, ClinGen CA382505476, ClinVar RCV003605530, MetaLR 0.54, MetaSVM -0.36, Likely pathogenic, Deficiency of acetyl-CoA acetyltransferase
- M1T (p.Met1Thr), rs120074142, ClinGen CA382505480, ClinVar RCV000844766, MetaLR 0.63, MetaSVM 0.41, Pathogenic, Deficiency of acetyl-CoA acetyltransferase
- M1V (p.Met1Val), rs1305448140, ClinGen CA382505477, ClinVar RCV000844765, MetaLR 0.54, MetaSVM -0.36, Pathogenic, Deficiency of acetyl-CoA acetyltransferase
- A2D (p.Ala2Asp), TOPMed rs915506786, gnomAD rs915506786, REVEL 0.16, CADD 22.60, Uncertain significance
- A2V (p.Ala2Val), rs915506786, ClinGen CA228390187, ClinVar RCV001337631, TOPMed rs915506786, REVEL 0.13, CADD 22.80, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- A2S (p.Ala2Ser), gnomAD 11-108121610-G-T, REVEL 0.14, CADD 18.60
- A2P (p.Ala2Pro), gnomAD 11-108121610-G-C, REVEL 0.14, CADD 20.10
- A2T (p.Ala2Thr), gnomAD 11-108121610-G-A, REVEL 0.13, CADD 19.90
- A2G (p.Ala2Gly), gnomAD 11-108121611-C-G, REVEL 0.12, CADD 21.80
- A2A (p.Ala2Ala), rs1467653213, gnomAD 11-108121612-T-A, CADD 9.72
- V3A (p.Val3Ala), Ensembl rs2077149362, REVEL 0.15, CADD 15.10
- V3M (p.Val3Met), ExAC rs770780507, gnomAD rs770780507, REVEL 0.14, AlphaMissense 0.08
- V3L (p.Val3Leu), gnomAD 11-108121613-G-C, REVEL 0.18, AlphaMissense 0.08
- V3E (p.Val3Glu), gnomAD 11-108121614-T-A, REVEL 0.39, CADD 18.50
- V3V (p.Val3Val), rs1254889695, gnomAD 11-108121615-G-A, CADD 16.00
- L4M (p.Leu4Met), ExAC rs774524997, gnomAD rs774524997, REVEL 0.19, CADD 12.90, Likely benign
- L4P (p.Leu4Pro), TOPMed rs1167146974, gnomAD rs1167146974, REVEL 0.23, CADD 20.20, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- L4V (p.Leu4Val), rs774524997, ClinGen CA382505494, ClinVar RCV001559199, ExAC rs774524997, REVEL 0.18, CADD 13.00, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- L4W (p.Leu4Trp), gnomAD 11-108121614-TG-T, CADD 22.80
- L4L (p.Leu4Leu), rs774524997, gnomAD 11-108121616-C-T, AlphaMissense 0.08, MetaLR 0.16
- A5P (p.Ala5Pro), rs3741056, ClinGen CA145604, cosmic curated COSV54919, ClinVar RCV000077929, REVEL 0.28, CADD 16.00, Benign, not specified; not provided; Deficiency of acetyl-CoA acetyltransferase
- A5V (p.Ala5Val), rs767448873, ClinGen CA6262981, ClinVar RCV003110215, ExAC rs767448873, REVEL 0.14, CADD 17.20, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- p.Ala5delinsGlyThrAlaValLeuPro, rs2077149832, gnomAD 11-108121619-G-GG, CADD 23.00
- A5S (p.Ala5Ser), gnomAD 11-108121619-G-T, REVEL 0.09, CADD 12.90
- A5T (p.Ala5Thr), gnomAD 11-108121619-G-A, REVEL 0.14, CADD 13.40
- A5E (p.Ala5Glu), gnomAD 11-108121620-C-A, REVEL 0.15, CADD 20.20
- A5A (p.Ala5Ala), rs886047594, gnomAD 11-108121621-G-A, CADD 14.40
- A6P (p.Ala6Pro), TOPMed rs1050634424, REVEL 0.39, CADD 18.10
- A6V (p.Ala6Val), TOPMed rs1440347190, gnomAD rs1440347190, REVEL 0.24, CADD 13.10
- A6S (p.Ala6Ser), gnomAD 11-108121622-G-T, REVEL 0.22, CADD 14.60
- A6T (p.Ala6Thr), gnomAD 11-108121622-G-A, REVEL 0.21, CADD 14.90
- A6E (p.Ala6Glu), gnomAD 11-108121623-C-A, REVEL 0.45, CADD 12.40
- A6A (p.Ala6Ala), rs1324457201, gnomAD 11-108121624-A-G, CADD 8.47
- L7I (p.Leu7Ile), gnomAD 11-108121625-C-A, REVEL 0.22, CADD 17.50
- L7F (p.Leu7Phe), gnomAD 11-108121625-C-T, REVEL 0.25, AlphaMissense 0.08
- L7H (p.Leu7His), gnomAD 11-108121626-T-A, REVEL 0.38, CADD 22.20
- L7L (p.Leu7Leu), gnomAD 11-108121627-T-C, CADD 16.90
- L8M (p.Leu8Met), ExAC rs775668624, TOPMed rs775668624, gnomAD rs775668624, REVEL 0.26, CADD 18.10, Likely benign
- L8R (p.Leu8Arg), TOPMed rs1837002130
- L8V (p.Leu8Val), ExAC rs775668624, TOPMed rs775668624, gnomAD rs775668624, REVEL 0.24, CADD 16.90, Likely benign
- L8L (p.Leu8Leu), rs775668624, gnomAD 11-108121628-C-T, CADD 17.10
- L8Q (p.Leu8Gln), gnomAD 11-108121629-T-A, REVEL 0.44, AlphaMissense 0.14
- L8P (p.Leu8Pro), gnomAD 11-108121629-T-C, REVEL 0.56, CADD 23.60
- R9C (p.Arg9Cys), NCI-TCGA TCGA novel, REVEL 0.40, CADD 22.40, Variant assessed as somatic; moderate impact.
- R9L (p.Arg9Leu), Ensembl rs2077150447, REVEL 0.32, CADD 14.60
- R9S (p.Arg9Ser), gnomAD 11-108121631-C-A, REVEL 0.35, CADD 19.10
- R9H (p.Arg9His), gnomAD 11-108121632-G-A, REVEL 0.28, CADD 14.80
- R9R (p.Arg9Arg), rs1437592865, gnomAD 11-108121633-C-T, CADD 9.44
- S10G (p.Ser10Gly), TOPMed rs2077150560, gnomAD rs2077150560, REVEL 0.21, CADD 16.00
- S10N (p.Ser10Asn), rs886047595, ClinGen CA10633268, ClinVar RCV000358143, TOPMed rs886047595, AlphaMissense 0.13, MetaLR 0.58, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- S10R (p.Ser10Arg), gnomAD rs1337885330, REVEL 0.21, CADD 13.40
- S10C (p.Ser10Cys), gnomAD 11-108121634-A-T, REVEL 0.25, CADD 15.70
- S10I (p.Ser10Ile), gnomAD 11-108121635-G-T, REVEL 0.25, CADD 18.70
- S10S (p.Ser10Ser), rs1337885330, gnomAD 11-108121636-C-T, CADD 13.30
- G11S (p.Gly11Ser), rs928949283, ClinGen CA228390227, ClinVar RCV003067171, gnomAD rs928949283, REVEL 0.20, CADD 13.60, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- G11R (p.Gly11Arg), gnomAD 11-108121637-G-C, REVEL 0.25, CADD 14.60
- G11C (p.Gly11Cys), gnomAD 11-108121637-G-T, REVEL 0.27, CADD 18.40
- G11D (p.Gly11Asp), gnomAD 11-108121638-G-A, REVEL 0.31, CADD 13.80
- G11V (p.Gly11Val), gnomAD 11-108121638-G-T, REVEL 0.21, CADD 13.40
- G11G (p.Gly11Gly), rs761018640, gnomAD 11-108121639-C-G, AlphaMissense 0.09, MetaLR 0.14
- A12S (p.Ala12Ser), 1000Genomes rs764674778, ExAC rs764674778, TOPMed rs764674778, gnomAD rs764674778, REVEL 0.28, CADD 9.69, Uncertain significance
- A12T (p.Ala12Thr), rs764674778, ClinGen CA6262984, ClinVar RCV001243860, ClinVar RCV002564076, REVEL 0.23, CADD 10.70, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase; Inborn genetic diseases
- A12D (p.Ala12Asp), gnomAD 11-108121641-C-A, REVEL 0.22, CADD 10.70
- A12V (p.Ala12Val), gnomAD 11-108121641-C-T, REVEL 0.20, CADD 11.40
- A12A (p.Ala12Ala), gnomAD 11-108121642-C-A, CADD 13.80
- R13G (p.Arg13Gly), TOPMed rs1211329032, gnomAD rs1211329032, REVEL 0.34, CADD 14.90
- R13H (p.Arg13His), ExAC rs754453264, gnomAD rs754453264, REVEL 0.28, CADD 18.30
- R13S (p.Arg13Ser), TOPMed rs1211329032, gnomAD rs1211329032, REVEL 0.44, CADD 10.70
- R13C (p.Arg13Cys), gnomAD 11-108121643-C-T, REVEL 0.31, CADD 13.50
- R13P (p.Arg13Pro), gnomAD 11-108121644-G-C, REVEL 0.41, AlphaMissense 0.95
- R13L (p.Arg13Leu), gnomAD 11-108121644-G-T, REVEL 0.33, AlphaMissense 0.95
- R13R (p.Arg13Arg), gnomAD 11-108121645-C-G, CADD 12.10
- S14R (p.Ser14Arg), gnomAD rs2077151380, REVEL 0.24, AlphaMissense 0.12
- S14G (p.Ser14Gly), gnomAD 11-108121646-A-G, REVEL 0.19, AlphaMissense 0.09
- S14I (p.Ser14Ile), gnomAD 11-108121647-G-T, REVEL 0.24, CADD 17.00
- S14S (p.Ser14Ser), rs1436280151, gnomAD 11-108121648-C-T, CADD 14.00
- R15C (p.Arg15Cys), rs757688736, ClinGen CA6262986, ClinVar RCV001970355, ExAC rs757688736, REVEL 0.31, CADD 21.80, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- R15P (p.Arg15Pro), gnomAD rs1240083923, REVEL 0.30, CADD 18.80
- R15S (p.Arg15Ser), gnomAD 11-108121649-C-A, REVEL 0.29, CADD 15.20
- R15L (p.Arg15Leu), gnomAD 11-108121650-G-T, REVEL 0.28, CADD 21.30
- R15H (p.Arg15His), gnomAD 11-108121650-G-A, REVEL 0.30, CADD 17.90
- R15R (p.Arg15Arg), rs2135283693, gnomAD 11-108121651-C-T, CADD 16.70
- S16R (p.Ser16Arg), TOPMed rs1196108614, gnomAD rs1196108614, Likely benign
- S16C (p.Ser16Cys), gnomAD 11-108121652-A-T, REVEL 0.30, CADD 9.60
- S16G (p.Ser16Gly), gnomAD 11-108121652-A-G, REVEL 0.21, CADD 9.96
- S16I (p.Ser16Ile), gnomAD 11-108121653-G-T, REVEL 0.19, CADD 15.80
- S16T (p.Ser16Thr), gnomAD 11-108121653-G-C, REVEL 0.21, CADD 16.40
- S16N (p.Ser16Asn), gnomAD 11-108121653-G-A, REVEL 0.14, CADD 16.30
- S16S (p.Ser16Ser), rs1196108614, gnomAD 11-108121654-C-T, CADD 14.60
- P17A (p.Pro17Ala), 1000Genomes rs573208198, TOPMed rs573208198, gnomAD rs573208198, REVEL 0.29, CADD 15.30, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- P17S (p.Pro17Ser), rs573208198, ClinGen CA228390238, ClinVar RCV002626959, 1000Genomes rs573208198, REVEL 0.28, CADD 15.60, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- P17T (p.Pro17Thr), gnomAD 11-108121655-C-A, REVEL 0.35, CADD 15.20
- P17H (p.Pro17His), gnomAD 11-108121656-C-A, REVEL 0.35, CADD 15.30
- P17L (p.Pro17Leu), gnomAD 11-108121656-C-T, REVEL 0.32, CADD 15.70
- P17P (p.Pro17Pro), gnomAD 11-108121657-C-T, CADD 16.70
- L18V (p.Leu18Val), TOPMed rs1462454471, gnomAD rs1462454471, REVEL 0.22, CADD 15.60, Uncertain significance, Inborn genetic diseases
- L18P (p.Leu18Pro), rs1476273214, gnomAD 11-108121653-G-GC, CADD 23.10
- L18C (p.Leu18Cys), gnomAD 11-108121653-GC-G, CADD 19.30
- L18M (p.Leu18Met), gnomAD 11-108121658-C-A, REVEL 0.23, CADD 15.50
- L18L (p.Leu18Leu), gnomAD 11-108121658-C-T, CADD 15.90
- L18Q (p.Leu18Gln), gnomAD 11-108121659-T-A, REVEL 0.42, CADD 19.90
- L19F (p.Leu19Phe), gnomAD 11-108121661-C-T, REVEL 0.21, CADD 16.90
- L19I (p.Leu19Ile), gnomAD 11-108121661-C-A, REVEL 0.27, CADD 16.10
- L19R (p.Leu19Arg), gnomAD 11-108121662-T-G, REVEL 0.47, AlphaMissense 0.08
- L19P (p.Leu19Pro), gnomAD 11-108121662-T-C, REVEL 0.58, CADD 20.40
- L19L (p.Leu19Leu), rs540416798, gnomAD 11-108121663-C-T, CADD 5.38
- R20R (p.Arg20Arg), rs1393009679, gnomAD 11-108121664-C-A, AlphaMissense 0.33, MetaLR 0.24
- R20W (p.Arg20Trp), gnomAD 11-108121664-C-T, REVEL 0.47, AlphaMissense 0.18
- R20Q (p.Arg20Gln), gnomAD 11-108121665-G-A, REVEL 0.30, CADD 18.90
- R20L (p.Arg20Leu), gnomAD 11-108121665-G-T, REVEL 0.44, CADD 19.40
- R21del (p.Arg21del), gnomAD 11-108121662-TCCG, CADD 17.40
- R21G (p.Arg21Gly), gnomAD 11-108121667-A-G, REVEL 0.30, CADD 23.60
- R21M (p.Arg21Met), gnomAD 11-108121668-G-T, REVEL 0.35, CADD 21.30
- R21K (p.Arg21Lys), gnomAD 11-108121668-G-A, REVEL 0.19, CADD 16.40
- R21R (p.Arg21Arg), gnomAD 11-108121669-G-A, CADD 17.50
- R21S (p.Arg21Ser), gnomAD 11-108121669-G-T, REVEL 0.27, CADD 19.00
- L22P (p.Leu22Pro), TOPMed rs1429772457, REVEL 0.34, CADD 19.90
- L22V (p.Leu22Val), TOPMed rs2077152090, gnomAD rs2077152090, REVEL 0.27, CADD 16.20
- L22M (p.Leu22Met), gnomAD 11-108121670-C-A, REVEL 0.32, CADD 18.20
- L22L (p.Leu22Leu), gnomAD 11-108121670-C-T, CADD 16.40
- V23L (p.Val23Leu), Ensembl rs375362239, REVEL 0.23, AlphaMissense 0.21
- V23M (p.Val23Met), gnomAD 11-108121673-G-A, REVEL 0.19, AlphaMissense 0.27
- V23V (p.Val23Val), gnomAD 11-108121675-G-T, CADD 18.40
- Q24* (p.Gln24Ter), rs2496516251, ClinGen CA382505606, ClinVar RCV003460285, CADD 44.00, Likely pathogenic
- Q24P (p.Gln24Pro), rs2077152202, ClinGen CA382505608, ClinVar RCV001278340, Ensembl rs2077152202, AlphaMissense 0.08, MetaLR 0.50, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- Q24K (p.Gln24Lys), gnomAD 11-108121676-C-A, REVEL 0.19, CADD 21.60
- Q24R (p.Gln24Arg), gnomAD 11-108121677-A-G, REVEL 0.25, AlphaMissense 0.12
- Q24L (p.Gln24Leu), gnomAD 11-108121677-A-T, REVEL 0.43, CADD 24.70
- Q24Q (p.Gln24Gln), gnomAD 11-108121678-G-A, CADD 24.20
- Q24H (p.Gln24His), gnomAD 11-108121678-G-T, REVEL 0.50, CADD 32.00
- E25D (p.Glu25Asp), TOPMed rs1167042233, gnomAD rs1167042233, REVEL 0.23, CADD 17.90
- E25K (p.Glu25Lys), gnomAD 11-108131907-G-A, REVEL 0.49, CADD 23.90
- E25* (p.Glu25Ter), gnomAD 11-108131907-G-T, CADD 41.00
- E25V (p.Glu25Val), gnomAD 11-108131908-A-T, REVEL 0.49, CADD 22.50
- E25G (p.Glu25Gly), gnomAD 11-108131908-A-G, REVEL 0.50, CADD 20.90
- E25E (p.Glu25Glu), gnomAD 11-108131909-A-G, CADD 15.00
- I26R (p.Ile26Arg), TOPMed rs2077368139
- I26V (p.Ile26Val), rs1352801361, ClinGen CA382506096, ClinVar RCV002914237, TOPMed rs1352801361, REVEL 0.19, CADD 13.40, Uncertain significance, Deficiency of acetyl-CoA acetyltransferase
- I26T (p.Ile26Thr), gnomAD 11-108131911-T-C, REVEL 0.23, CADD 18.40
- I26M (p.Ile26Met), gnomAD 11-108131912-A-G, REVEL 0.21, CADD 16.20
- R27* (p.Arg27Ter), rs1591360326, ClinGen CA382506102, ClinVar RCV000844767, Ensembl rs1591360326, CADD 33.00, Pathogenic
- R27I (p.Arg27Ile), NCI-TCGA Cosmic COSV5492, cosmic curated COSV54920, Variant assessed as somatic; moderate impact.
- R27G (p.Arg27Gly), gnomAD 11-108131913-A-G, REVEL 0.51, CADD 17.40
- R27K (p.Arg27Lys), gnomAD 11-108131914-G-A, REVEL 0.16, CADD 7.80
- R27S (p.Arg27Ser), gnomAD 11-108131915-A-T, REVEL 0.18, CADD 17.10
- R27R (p.Arg27Arg), gnomAD 11-108131915-A-G, CADD 10.50
- Y28H (p.Tyr28His), ExAC rs775374421, gnomAD rs775374421, REVEL 0.12, CADD 8.64
- Y28C (p.Tyr28Cys), rs749873354, gnomAD 11-108131914-GAT-, CADD 22.30
- Y28Y (p.Tyr28Tyr), rs760794308, gnomAD 11-108131918-T-C, CADD 0.98
- Y28* (p.Tyr28Ter), gnomAD 11-108131918-T-G, CADD 25.90
- V29L (p.Val29Leu), rs764142914, ClinGen CA6263005, cosmic curated COSV54920, ClinVar RCV000444703, REVEL 0.18, CADD 0.20, Uncertain significance, Inborn genetic diseases; not provided
- V29M (p.Val29Met), ExAC rs764142914, TOPMed rs764142914, gnomAD rs764142914, REVEL 0.14, CADD 1.77, Uncertain significance
- V29G (p.Val29Gly), gnomAD 11-108131917-ATG-, CADD 15.20
- V29E (p.Val29Glu), gnomAD 11-108131920-T-A, REVEL 0.29, CADD 14.30
- V29A (p.Val29Ala), gnomAD 11-108131920-T-C, REVEL 0.15, CADD 10.20
- V29V (p.Val29Val), rs777242705, gnomAD 11-108131921-G-A, CADD 7.19
- E30G (p.Glu30Gly), TOPMed rs2077368534, REVEL 0.19, CADD 17.70
- E30Q (p.Glu30Gln), TOPMed rs1451797522
- E30N (p.Glu30Asn), gnomAD 11-108131920-TG-T, CADD 22.90
- E30* (p.Glu30Ter), gnomAD 11-108131922-G-T, CADD 35.00
- E30K (p.Glu30Lys), gnomAD 11-108131922-G-A, REVEL 0.16, CADD 15.80
- E30E (p.Glu30Glu), gnomAD 11-108131924-A-G, CADD 2.30
- R31Q (p.Arg31Gln), cosmic curated COSV54921, ExAC rs765645574, TOPMed rs765645574, gnomAD rs765645574, REVEL 0.66, CADD 27.10
- R31W (p.Arg31Trp), rs199952982, ClinGen CA220231, cosmic curated COSV54921, ClinVar RCV000077935, REVEL 0.73, CADD 25.60, Uncertain significance, not provided; Deficiency of acetyl-CoA acetyltransferase
- R31R (p.Arg31Arg), gnomAD 11-108131925-C-A, CADD 9.48
- R31L (p.Arg31Leu), gnomAD 11-108131926-G-T, REVEL 0.73, CADD 23.50
- S32R (p.Ser32Arg), Ensembl rs2077368677, REVEL 0.47, CADD 18.90
- S32G (p.Ser32Gly), gnomAD 11-108131928-A-G, REVEL 0.18, CADD 19.60
- S32C (p.Ser32Cys), gnomAD 11-108131928-A-T, REVEL 0.52, CADD 20.30
- S32N (p.Ser32Asn), gnomAD 11-108131929-G-A, REVEL 0.16, CADD 12.90
- S32S (p.Ser32Ser), gnomAD 11-108131930-T-C, CADD 9.51
- Y33* (p.Tyr33Ter), rs1469248513, ClinGen CA382506146, ClinVar RCV000844770, TOPMed rs1469248513, CADD 31.00, Pathogenic
- Y33H (p.Tyr33His), gnomAD 11-108131931-T-C, REVEL 0.50, CADD 20.40
- Y33C (p.Tyr33Cys), gnomAD 11-108131932-A-G, REVEL 0.61, CADD 19.50
- Y33Y (p.Tyr33Tyr), rs1469248513, gnomAD 11-108131933-T-C, CADD 2.89
- V34E (p.Val34Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V34I (p.Val34Ile), ExAC rs750824793, gnomAD rs750824793, REVEL 0.18, CADD 12.80
- V34A (p.Val34Ala), gnomAD 11-108131935-T-C, REVEL 0.18, CADD 0.80
- V34V (p.Val34Val), gnomAD 11-108131936-A-G, CADD 3.95
Public ACAT1 analysis runs
- ACAT1 analysis run — ACAT1 (715 variants) — completed 2026-08-22